LEXX

Lexaria Bioscience Corp.

$0.53 -0.03 (-5.36%) At close · Jul 7

Market Cap

$13.14M

24,787,446

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-03-17	BUNKA CHRISTOPHER	Director	Gift Filing footnotes — common shares (Direct) The 100,000 shares were gifted back to Lexaria Bioscience Corp. and returned to treasury.	common shares	100,000	—	—	273,543
2025-07-30	BUNKA CHRISTOPHER	Director	Buy	common shares (I)	11,900	$0.91	$10,866	281,912
2025-07-29	Carle Vanessa	Secretary	Buy	common shares	750	$0.91	$683	750
2025-07-29	CHRISTOPHER RICHARD	Director, Chief Executive Officer	Buy	common shares	15,000	$0.91	$13,641	65,000
2025-07-29	DOCHERTY JOHN MARTIN	Director, President & CSO	Buy	common shares	5,376	$0.93	$4,989	5,376
2025-07-29	BUNKA CHRISTOPHER	Director	Buy	common shares (I)	15,600	$0.92	$14,375	270,012
2025-07-29	McKechnie William Edward	Director	Buy	common shares	5,000	$0.91	$4,532	18,191
2025-05-15	DOCHERTY JOHN MARTIN	Director, President & CSO	Award	Stock Options	150,000	—	—	310,834
2025-05-15	Bhullar Baljinder	Director	Award	Stock Options	11,000	—	—	11,000
2025-05-15	REESE ALBERT L JR	Director	Award	Stock Options	11,000	—	—	43,000
2025-05-15	Carle Vanessa	Secretary	Award	Stock Options	15,000	—	—	75,000
2025-05-15	Baxter Nicholas W	Director	Award	Stock Options	11,000	—	—	63,000
2025-05-15	McKechnie William Edward	Director	Award	Stock Options	11,000	—	—	63,000
2025-05-15	Shankman Michael Elliot	Chief Financial Officer	Award	Stock Options	50,000	—	—	100,000
2025-05-15	BUNKA CHRISTOPHER	Director	Award	Stock Options	11,000	—	—	184,834
2025-05-15	CHRISTOPHER RICHARD	Director, Chief Executive Officer	Award	Stock Options	150,000	—	—	350,000
2025-01-07	BUNKA CHRISTOPHER	Director	Award Filing footnotes — Restricted Stock Award (Direct) The closing price on the Issuer's shares on the date of grant was $2.24. Beneficial ownership reflects the aggregate securities held directly.	Restricted Stock Award	100,000	—	—	373,543
2024-12-03	CHRISTOPHER RICHARD	Director, Chief Executive Officer	Buy	common shares	27,172	$2.47	$67,175	50,000
2024-12-02	CHRISTOPHER RICHARD	Director, Chief Executive Officer	Buy	common shares	22,828	$2.24	$51,217	22,828
2024-08-12	TURKEL CATHERINE C.	Director	Buy	common shares	1,600	$3.13	$5,008	3,100
2024-07-31	Carle Vanessa	Secretary	Sell	common shares	2,567	$4.00	$10,268	0
2024-07-26	TURKEL CATHERINE C.	Director	Award	Stock Options	12,000	—	—	27,000
2024-07-26	Baxter Nicholas W	Director	Award	Stock Options	12,000	—	—	52,000
2024-07-26	McKechnie William Edward	Director	Award	Stock Options	12,000	—	—	52,000
2024-07-26	REESE ALBERT L JR	Director	Award	Stock Options	12,000	—	—	32,000
2024-05-14	Carle Vanessa	Secretary	Convert	common shares	2,500	$1.15	$2,875	2,567
2024-05-14	Carle Vanessa	Secretary	Convert	Stock Options	2,500	—	—	60,067
2024-04-26	Baxter Nicholas W	Director	Award	Stock Options	5,000	—	—	40,000
2024-04-26	REESE ALBERT L JR	Director	Award	Stock Options	5,000	—	—	20,000
2024-04-26	TURKEL CATHERINE C.	Director	Award	Stock Options	5,000	—	—	15,000
2024-04-26	BUNKA CHRISTOPHER	Director	Award	Stock Options	49,500	—	—	180,501
2024-04-26	McKechnie William Edward	Director	Award	Stock Options	5,000	—	—	40,000
2024-04-26	Carle Vanessa	Secretary	Award	Stock Options	10,000	—	—	62,567
2024-04-26	DOCHERTY JOHN MARTIN	Director, President & CSO	Award	Stock Options	49,500	—	—	174,168
2023-10-26	DOCHERTY JOHN MARTIN	Director, President & CSO	Award	Stock Options	30,000	—	—	124,668
2023-10-26	Carle Vanessa	Secretary	Award	Stock Options	12,500	—	—	52,567
2023-10-26	BUNKA CHRISTOPHER	Director	Award	Stock Options	30,000	—	—	131,001
2023-07-25	TURKEL CATHERINE C.	Director	Award	Stock Options	5,000	—	—	10,000
2023-07-25	REESE ALBERT L JR	Director	Award	Stock Options	5,000	—	—	15,000
2023-07-25	Baxter Nicholas W	Director	Award	Stock Options	5,000	—	—	35,000
2023-07-25	McKechnie William Edward	Director	Award	Stock Options	5,000	—	—	35,000
2023-02-09	TURKEL CATHERINE C.	Director	Buy	Common Shares	1,500	$2.84	$4,267	1,500
2022-10-14	Downey Gregory	Chief Financial Officer	Buy Filing footnotes — common shares (Direct) This Form 4A is being filed to correct the transaction code for the open market purchase made by Mr. Downey as originally notated as a grant or award in the Form 4 filed on October 18, 2022.	common shares	121	$2.09	$253	1,954
2022-10-13	BUNKA CHRISTOPHER	Director	Buy Filing footnotes — common shares (Indirect) This Form 4/A is being filed to correct the transaction code for the open market purchase of common shares made by Mr. Bunka as previously notated as a grant or award in the Form 4 originally filed on 10/13/2022.	common shares (I)	16,600	$2.10	$34,860	254,412
2022-10-12	McKechnie William Edward	Director	Award	Stock Options	18,200	—	—	30,000
2022-10-12	TURKEL CATHERINE C.	Director	Award	Stock Options	1,600	—	—	5,000
2022-10-12	BUNKA CHRISTOPHER	Director	Buy Filing footnotes — common shares (Indirect) This Form 4/A is being filed to correct the transaction code for the open market purchase of common shares made by Mr. Bunka as previously notated as a grant or award in the Form 4 originally filed on 10/13/2022.	common shares (I)	21,900	$1.99	$43,537	237,812
2022-10-12	REESE ALBERT L JR	Director	Award	Stock Options	3,200	—	—	10,000
2022-10-12	Baxter Nicholas W	Director	Award	Stock Options	18,200	—	—	30,000
2022-09-02	TURKEL CATHERINE C.	Director	Other	No Securities Owned	0	—	—	0

Showing 1–50 of 116 transactions

Key facts CIK 1348362 CUSIP 52886N406 Visit website